Psycho-Oncology: Discover How Stress Causes Cancer
Phase 1 of Cancer: Inescapable Shock
Phase 2 of Cancer: Adrenaline Depletion
Phase 3 of Cancer: The Cancer Fungus
Phase 4 of Cancer: Niacin Deficiency
Phase 5 of Cancer: Vitamin C Depletion
Phase 6 of Cancer: Immune Suppression
LIQUID CESIUM CHLORIDE / DMSO: CANCER TREATMENT
Liquid Cesium Chloride is a highly alkaline element used to raise the pH levels of cancer cells to 8.0 or greater. Otto Warburg won a Nobel prize for showing that cancer thrives in anaerobic (without oxygen), or acidic, conditions. Research by Keith Brewer, PhD and H.E. Sartori has shown that raising the pH, or oxygen content, range of a cell to 8.0 creates a deadly environment for cancer. The pH scale ranges from 0 to 14, with numbers below 7 representing an acidic condition and above 7 representing an alkaline, or oxygenated, condition. When liquid cesium chloride is taken up by cancer cells, it raises the pH, or oxygen content, of the cell. The cells that die are absorbed and eliminated by the body. The Liquid Cesium Chloride Protocol (Liquid Cesium Chloride + DMSO) directly targets cancer cells, and is not ingested by normal cells. Liquid Cesium Chloride immediately stops the metastasis of the cancer, can start shrinking tumour masses within weeks, and almost always stops the pain of cancer within 24-48 hours. It is most effective for bone / brain cancers and other fast growing cancers. Liquid Cesium Chloride is nearly always administered with DMSO. DMSO is a super-solvent. It binds to water (which makes up around 65% of the body) better than water does, giving DMSO the ability to penetrate every single cell of the body, so whatever its other effects may be, they will be spread systemically through the entire body. Whatever is administered with DMSO tends to bind with the DMSO and is carried to the inside of cells along with DMSO. If cytotoxic drugs are given to fight a cancer, or in this case Cesium Chloride, they are more effective when given with DMSO to escort them to the inside of cancer cells. DMSO also relieves the pain of cancer and, by being a free radical scavenger, reduces the side effects of radiation therapy. Animal studies show that DMSO, by itself, inhibits the growth of breast, colon and bladder cancer, as well as leukemia, in animals. The Liquid Cesium Chloride Protocol can be self-administered at home under the telephone guidance of an experienced professional and is normally applied to the skin externally in a localized area (such as the abdomen) using a spray bottle. DMSO is sulfur-based and has a pungent sulfur smell that will be noticed by others when applied to the skin.
LIQUID CESIUM CHLORIDE SIDE-EFFECTS
There are many side effects of Liquid Cesium Chloride including inflammation, swelling and pain, muscle cramps, feet turning purple or feeling frost bite when you have taken too much liquid cesium chloride, your finger tips feeling like needles and pins, or a tingly prickly feeling in your hands or on your face, nausea and vomiting (if you have taken cesium internally - note liquid cesium chloride should always be applied eternally to the skin), itchiness, dry skin, frequently wanting to urinate, cramping, and dark dried blood in the urine (the last being a good sign) as the kidneys are expelling dead tissue. List of side effects visit: [www.cancertutor.com/Cancer/Alkaline.html].
The following is an extract from the American Cancer Society on Liquid Cesium Chloride and possible complications: "In a case report from 1984, one person described his own experiences after taking cesium chloride for 36 days. He took 3 grams of cesium chloride dissolved in fluid after his morning and evening meals, which consisted of an alternative dietary regimen. He describes an “initial general feeling of well-being and heightened sense perception,” as well as nausea, diarrhea, and tingling of his lips, hands, and feet. This case report is very different from a clinical trial involving many patients and is not helpful in deciding on a safe dose of cesium. Another person, who may be younger, older, smaller, or less healthy than this individual may not do well with this dose. In fact, several recent case reports have described serious side effect in people with cancer taking similar doses, including life-threatening problems with heart rhythm, seizures, loss of consciousness, and electrolyte (blood chemistry) imbalances in patients who were taking cesium. Full information on the acute and chronic toxicity of this substance is not fully known. Consuming large amounts of cesium could result in nausea, diarrhea, disturbed heart rhythm, loss of consciousness, or even death. Based on results of animal studies, women who are pregnant or breast-feeding should avoid taking cesium chloride supplements. Relying on this type of treatment alone, and avoiding conventional medical care, may also have serious health consequences."
See also fatal outcome of Cesium Chloride toxicity in cancer patient: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868249/]
The purpose of Liquid Cesium Chloride is to make the body's cells alkaline, to a pH level of 8.0 or greater, to prevent further cell mutation and to reduce tumour mass. If you are not happy with the potential side effects, a safer and effective alternative is Pleo-Sanuvis (Dextrorotatory Lactic Acid).
The following is an extract from the American Cancer Society on Liquid Cesium Chloride and possible complications: "In a case report from 1984, one person described his own experiences after taking cesium chloride for 36 days. He took 3 grams of cesium chloride dissolved in fluid after his morning and evening meals, which consisted of an alternative dietary regimen. He describes an “initial general feeling of well-being and heightened sense perception,” as well as nausea, diarrhea, and tingling of his lips, hands, and feet. This case report is very different from a clinical trial involving many patients and is not helpful in deciding on a safe dose of cesium. Another person, who may be younger, older, smaller, or less healthy than this individual may not do well with this dose. In fact, several recent case reports have described serious side effect in people with cancer taking similar doses, including life-threatening problems with heart rhythm, seizures, loss of consciousness, and electrolyte (blood chemistry) imbalances in patients who were taking cesium. Full information on the acute and chronic toxicity of this substance is not fully known. Consuming large amounts of cesium could result in nausea, diarrhea, disturbed heart rhythm, loss of consciousness, or even death. Based on results of animal studies, women who are pregnant or breast-feeding should avoid taking cesium chloride supplements. Relying on this type of treatment alone, and avoiding conventional medical care, may also have serious health consequences."
See also fatal outcome of Cesium Chloride toxicity in cancer patient: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868249/]
The purpose of Liquid Cesium Chloride is to make the body's cells alkaline, to a pH level of 8.0 or greater, to prevent further cell mutation and to reduce tumour mass. If you are not happy with the potential side effects, a safer and effective alternative is Pleo-Sanuvis (Dextrorotatory Lactic Acid).
TELEPHONE SUPPORT
As the Liquid Cesium Chloride/DSMO protocol is self-administered at home under the guidance of an experienced telephone professional, it is important to be comfortable that you will receive on-going, consistent, and immediate support when you need it during your treatment. We referred a few patients to one such recommended vendor, Dr Darrel Wolfe PhD, of the Wolfe Clinic. The feedback we received from these patients was poor. Dr Wolfe was so busy (with an overwhelming number of other patients), that it was very difficult for these patients to discuss side effects or on-going complications with him at the time they needed. One patient had to wait nearly a week before Dr Wolfe was available. This lack of support can be dangerous and put the patient at risk. Other support can be obtained from [www.nutrition2000.com] and [www.essense-of-life.com], however we recommend you discuss the subject of immediate and on-going support during your treatment.*** Read further: An Interview with Larry of Essense-of-Life. *** UPDATE October 2020: The FDA (The U.S. Food & Drug Administration) has issued warning letters to companies (including www.essense-of-life.com) whom they claim are illegally selling cesium chloride as either a treatment for illness or as a dietary supplement, to stop this action immediately. As a result, it appears liquid cesium chloride is no longer available for purchase.
LACK OF SURVIVAL STUDIES
Unfortunately, in Dr Keith Brewer's study of all 30 patients surviving cancer, he makes no mention of how long they survived for. Also, Dr Brewer uses Liquid Cesium Chloride with other leading anti-cancer products in his studies, so it is difficult to determine whether it was the Liquid Cesium Chloride or the other components of the combined therapy that was the cause of the increased survival. Liquid Cesium Chloride was used with other anti-cancer products in the Dr Sartori cancer therapy program as well, meaning that it is unknown whether the Liquid Cesium Chloride itself was the key ingredient in extended survival. Liquid Cesium Chloride together with DMSO, is almost always administered with Selenium, Potassium, Vitamins A, C, Zinc, and Laetrile for increased effectiveness as a COMBINED THERAPY approach. Each of these are well-known anti-cancer treatments on their own. Dr Hans Nieper of Germany, who also advocated the use of Liquid Cesium Chlroide as well as other anti-cancer products, was well-known for not providing any follow up survival statistics. Although the theory of this protocol is sound and there is fair evidence that liquid cesium chloride and DMSO do what they claim, there is insufficient patient feedback or studies to indicate any survival statistics at this time.
CLINICAL RESULTS WITH CESIUM COMBINED THERAPY
By Dr. James Howenstine, MD: Dr. H. E. Sartori began his cesium cancer therapy program in April 1981 at Life Sciences Universal Medical Clinics in Rockville, Md. Fifty patients with widespread metastatic tumor deposits were treated. Forty-seven of these 50 patients had already completed maximal modalities of treatment, i.e. surgery, radiation, multiple courses of chemotherapy before cesium was tried. Their condition was hopeless. Cesium chloride was given in 3 equal divided doses of 6 to 9 grams daily. Supplemental vitamin A emulsion (100,000 to 300,000 U), vitamin C (4 to 30 grams), zinc (80 to 100 mg, selenium (600 to 1200 mg), and amygadalin (1500 mg) were given plus other supplements. The diet consisted primarily of whole grains, vegetables, linolenic acid rich foods (flaxseed, walnut, soy, wheat germ) and other supplemented food. EDTA (chelation, dimethylsulfoxide (DMSO) and a combination of vitamins K, and magnesium salts were also given. The types of malignancies treated included 10 patients with breast cancer, 9 with colon cancer, 6 with prostate cancer, 4 had pancreatic cancer, 5 had lung cancer, 3 had liver cancer (hepatoma), 3 had lymphoma, 1 had Ewing's sarcoma of the pelvis, 1 had an adenocarcinoma and 8 had cancer from an unknown site of origin.
Approximately 50% of patients with breast, colon, prostate, pancreas and lung cancer survived. Three patients were comatose when the therapy was initiated. Thirteen patients died in the first 2 weeks of therapy. Autopsy results in each of these 13 disclosed reduction in tumor mass size caused by cesium therapy. Also pain disappeared in all patients within 1 to 3 days after initiation of cesium therapy. This may have reflected decreased production of lactic acid by dying cancer cells. One breast cancer patient was of considerable interest. She was comatose when cesium therapy was initiated using a feeding tube. She received 10 grams of cesium chloride three times daily. She walked out of the hospital 5 days later. Unfortunately it was not appreciated that a hip had been completely replaced by tumor tissue which disappeared with therapy. Having no bony tissue to support her weight she fell at home fracturing her neck resulting in death. The autopsy revealed no hip bone and only very small amounts of cancer tissue. This is a spectacular therapeutic result despite the tragic death. In a group of 8 patients where the site of origin of the malignancy was unknown 2 patients died in the first 14 days and 2 more died in the first year. Four of the patients were still alive when last heard from more than a year later. Conventional cancer therapy has never produced any results like these as similar cases without a clear site of origin for cancer usually die rapidly. A patient with lymphoma had a huge hard abdomen. He weighed 250 pounds. 120 pounds of weight was lost in the first 3 months of cesium therapy. His spleen was initially in his pelvis. This shrank to nearly normal size. The liver was enlarged to the umbilicus before therapy. This returned to normal size in 3 months. He was alive 3 years later at which time he was again taking chemotherapy.
Dr. Sartori believes that doses of cesium should not exceed 20 to 40 grams daily because of side effects of nausea and diarrhea. He felt that these results confirmed earlier results by Messiha which had suggested that large doses of cesium seemed to be more effective than low doses. Dr. Sartori took 40 grams of cesium himself which caused only nausea and unusual sensations around the mouth believed to be related to potassium depletion. The usual dosage used in his clinic was 2 or 3 grams three times daily. When there is no remaining sign of cancer he thinks the dose can be safely reduced to .5 or 1 gram daily. Some patients on cesium develop evidence of potassium depletion so serum potassium needs to be monitored along with uric acid blood levels. Any alkali therapy changes the pH of the body toward a more alkalotic state. This causes movement of potassium into cells which may result in low serum potassium values. This movement of potassium into cells means that a person can become seriously depleted of potassium even if there is no diarrhea or vomiting. A case of primary liver cancer (hepatoma) was treated later. She was a 39 year old school teacher who was terminal on arrival on April 25, 1984. Her liver was enlarged 1 inch below the umbilicus. She walked out of the hospital on May 10, 1984. Her liver had shrunk to 2 inches above the umbilicus. The alpha fetoprotein tumor marker for hepatoma had decreased from 39,000 units to 5000 units. On one occasion Dr. Sartori noticed the disappearance of metastatic tumor masses within one hour of cesium therapy. Two days later wrinkles appeared in the skin where the tumor masses had been located.
Physicist A. Keith Brewer became very interested in cancer in the 1930s. He performed fundamental research on the membranes surrounding normal cells, rapidly growing cells (embryonal and cancerous) and dead tissue. The methods used by him included spectrographic, fluorescence decay patterns, and phosphorescence decay patterns of radioisotopes of potassium in nature. He felt that he was one of only a few persons who had actually studied ion transport across membranes. His research enabled him to devise a protocol to treat cancer patients using cesium. Dr. Brewer then treated 30 patients with various cancers using cesium with all subjects surviving. The patients he treated were obviously not as sick as those in Dr. Sartori's group but his results provide further very encouraging evidence about cesium's value. Rescuing 25 cancer victims from certain death is a remarkable accomplishment for cesium therapy. Conventional therapy for malignancies using chemotherapy and radiation has never been able to cure patients whose initial tumor has spread to another site i.e. liver, lung, brain, etc. The nearly deceased patients treated by Dr. Sartori had tumor deposits scattered all over their bodies. A sizeable number (50 %) of these patients recovered. Additionally, it is unheard of for a patient whose site of origin of a tumor remains unknown to recover. In Dr. Sartori's series 4 out of 8 such patients were alive one year later. Sartori Paper #1 Sartori Paper #2 Sartori Paper #3 Sartori Paper #4 Sartori Paper #5
Approximately 50% of patients with breast, colon, prostate, pancreas and lung cancer survived. Three patients were comatose when the therapy was initiated. Thirteen patients died in the first 2 weeks of therapy. Autopsy results in each of these 13 disclosed reduction in tumor mass size caused by cesium therapy. Also pain disappeared in all patients within 1 to 3 days after initiation of cesium therapy. This may have reflected decreased production of lactic acid by dying cancer cells. One breast cancer patient was of considerable interest. She was comatose when cesium therapy was initiated using a feeding tube. She received 10 grams of cesium chloride three times daily. She walked out of the hospital 5 days later. Unfortunately it was not appreciated that a hip had been completely replaced by tumor tissue which disappeared with therapy. Having no bony tissue to support her weight she fell at home fracturing her neck resulting in death. The autopsy revealed no hip bone and only very small amounts of cancer tissue. This is a spectacular therapeutic result despite the tragic death. In a group of 8 patients where the site of origin of the malignancy was unknown 2 patients died in the first 14 days and 2 more died in the first year. Four of the patients were still alive when last heard from more than a year later. Conventional cancer therapy has never produced any results like these as similar cases without a clear site of origin for cancer usually die rapidly. A patient with lymphoma had a huge hard abdomen. He weighed 250 pounds. 120 pounds of weight was lost in the first 3 months of cesium therapy. His spleen was initially in his pelvis. This shrank to nearly normal size. The liver was enlarged to the umbilicus before therapy. This returned to normal size in 3 months. He was alive 3 years later at which time he was again taking chemotherapy.
Dr. Sartori believes that doses of cesium should not exceed 20 to 40 grams daily because of side effects of nausea and diarrhea. He felt that these results confirmed earlier results by Messiha which had suggested that large doses of cesium seemed to be more effective than low doses. Dr. Sartori took 40 grams of cesium himself which caused only nausea and unusual sensations around the mouth believed to be related to potassium depletion. The usual dosage used in his clinic was 2 or 3 grams three times daily. When there is no remaining sign of cancer he thinks the dose can be safely reduced to .5 or 1 gram daily. Some patients on cesium develop evidence of potassium depletion so serum potassium needs to be monitored along with uric acid blood levels. Any alkali therapy changes the pH of the body toward a more alkalotic state. This causes movement of potassium into cells which may result in low serum potassium values. This movement of potassium into cells means that a person can become seriously depleted of potassium even if there is no diarrhea or vomiting. A case of primary liver cancer (hepatoma) was treated later. She was a 39 year old school teacher who was terminal on arrival on April 25, 1984. Her liver was enlarged 1 inch below the umbilicus. She walked out of the hospital on May 10, 1984. Her liver had shrunk to 2 inches above the umbilicus. The alpha fetoprotein tumor marker for hepatoma had decreased from 39,000 units to 5000 units. On one occasion Dr. Sartori noticed the disappearance of metastatic tumor masses within one hour of cesium therapy. Two days later wrinkles appeared in the skin where the tumor masses had been located.
Physicist A. Keith Brewer became very interested in cancer in the 1930s. He performed fundamental research on the membranes surrounding normal cells, rapidly growing cells (embryonal and cancerous) and dead tissue. The methods used by him included spectrographic, fluorescence decay patterns, and phosphorescence decay patterns of radioisotopes of potassium in nature. He felt that he was one of only a few persons who had actually studied ion transport across membranes. His research enabled him to devise a protocol to treat cancer patients using cesium. Dr. Brewer then treated 30 patients with various cancers using cesium with all subjects surviving. The patients he treated were obviously not as sick as those in Dr. Sartori's group but his results provide further very encouraging evidence about cesium's value. Rescuing 25 cancer victims from certain death is a remarkable accomplishment for cesium therapy. Conventional therapy for malignancies using chemotherapy and radiation has never been able to cure patients whose initial tumor has spread to another site i.e. liver, lung, brain, etc. The nearly deceased patients treated by Dr. Sartori had tumor deposits scattered all over their bodies. A sizeable number (50 %) of these patients recovered. Additionally, it is unheard of for a patient whose site of origin of a tumor remains unknown to recover. In Dr. Sartori's series 4 out of 8 such patients were alive one year later. Sartori Paper #1 Sartori Paper #2 Sartori Paper #3 Sartori Paper #4 Sartori Paper #5
TESTS ON MICE AND HUMANS WITH CESIUM COMBINED THERAPY
Tests on Mice and Humans By A. Keith Brewer, Ph.D. A. Keith Brewer Science Library, 325 N. Central Ave., Richland Center, WI 53581: BREWER, A. K. The high pH therapy for cancer tests on mice and humans. PHARMACOL BIOCHEM BEHAV 21: Suppl. 1, 1-5. 1984.---Mass spectrographic and isotope studies have shown that potassium, rubidium, and especially cesium are most efficiently taken up by cancer cells. This uptake was enhanced by Vitamins A and C as well as salts of zinc and selenium. The quantity of cesium taken up was sufficient to raise the cell to the 8 pH range. Where cell mitosis ceases and the life of the cell is short. Tests on mice fed cesium and rubidium showed marked shrinkage in the tumor masses within 2 weeks. In addition, the mice showed none of the side effects of cancer. Tests have been carried out on over 30 humans. In each case the tumor masses disappeared. Also all pains and effects associated with cancer disappeared within 12 to 36 hr; the more chemotherapy and morphine the patient had taken, the longer the withdrawal period. Studies of the food intake in areas where the incidences of cancer are very low showed that it met the requirements for the high pH therapy.
The ready uptake of cesium and rubidium by the cancer cells lead the writer to the High pH therapy. This consists of feeding the patient close to 6 g of CsCl or RbCl per day in conjunction with the administration of ascorbic and retionic acids, Vitamins C and A, which being weak acids, upon absorption by the tumor cells will enhance the negative potential gradient across the membrane, and also zinc and selenium salts which, when absorbed on the membrane surface, will act as broad and moderately strong electron donors. Both types of compounds have been shown in mice to drastically enhance the pickup for cesium and rubidium ions. The toxic dose for CsCl is 135 g. The administration of 6 g per day therefore has no toxic effects. It is sufficient however to give rise to the pH in the cancer cells, bringing them up in a few days to the 8 or above where the life of the cell is short. In addition, the presence of Cs and Rb salts in the body fluids neutralizes the acid toxins leaking out of the tumor mass and renders them nontoxic.
Tests on Mice - The High pH therapy was first tested at American University in Washington, DC using mice. In these tests, 2 mm cubes of mammary tumors were implanted in the abdomens of mice and allowed to grow for 8 days. The mice were then divided into two groups. Both groups were continued on mouse chow, but the test group was given 1.11 g of rubidium carbonate by mouth per day in aqueous solution. After 13 more days the controls were starting to die so all mice were sacrificed and the tumors removed and weighed. The tumors in the test animals weighed only one eleventh of those in the controls. In addition, the test animals were showing none of the adverse effects of having cancer [3]. Results similar to those mentioned above were obtained at Platteville, WI using CsCl. More recently, Platteville has studied intraperitoneal injection of cesium carbonate for mice with abdominal tumor implants with 97% curative effect. Tests using intraperitoneal injections of CsCl were carried out by Messiha et al. [21]. The results were most successful and showed a drastic shrinkage in the tumor masses.
Tests on Man - Many tests on humans have been carried out by H. Nieper in Hannover, Germany and by H. Sartori in Washington, DC as well as by a number of other physicians. On the whole, the results have been very satisfactory. It has been observed that all pains associated with cancer disappear within 12 to 24 hr, except in a very few cases where there was a morphine withdrawal problem that required a few more hours. In these tests 2 g doses of CsCl were administered three times per day after eating. In most cases 5 to 10 g of Vitamin C and 100,000 units of Vitamin A, along with 50 to 100 mg of zinc, were also administered. Both Nieper and Sartori were also administering nitrilosides in the form of laetrile. There are good reasons to believe that the laetrile may be more effective than the vitamins in enhancing the pickup of cesium by the cells. In addition to the loss of pains, the physical results are a rapid shrinkage of the tumor masses. The material comprising the tumors is secreted as uric acid in the urine; the uric acid content of the urine increases many fold. About 50% of the patients were pronounced terminal, and were not able to work. Of these, a majority have gone back to work. Two side effects have been observed in some of the patients. These are first nausea, and the second diarrhea. Both depend upon the general condition of the digestive tract. Nieper feels that nausea can be prevented by administering the cesium in a solution of sorbitol. The diarrhea may, to some extent, be affected by the Vitamin C.
Only one case history will be presented here. A woman with 2 hard tumor masses 8 to 10 cm in diameter, one on her thyroid and one on her chest, was given 3 to 6 months to live. She had been subjected to chemotherapy, but was discontinued because it weakened her. She was taking laetrile on her own. She was given a 50 g bottle of CsCl and was told to take 4 g per day. She reported her case a year later. Being very frightened she took the entire 50 g in one week. At the end of that time the tumor masses were very soft, so she obtained another 50 g of CsCl and took it in another week. By the end of that time she could not find the tumors, and two years later there was no sign of their return. [Note: Dr. Hans Alfred Nieper, of Hannover, Germany, (now passed) was an oncologist consulted by prominent persons including Red Buttons, Yul Brynner and Ronald Reagan. He was president of the German Society of Oncology].
The Hopi Indians of Arizona - The incidence of cancer among the Hopi Indians is 1 in 1000 as compared to 1 in 4 for the USA as a whole. Fortunately their food has been analyzed from the standpoint of nutritional values [17]. In this study it was shown that the Hopi food runs higher in all the essential minerals than conventional foods. It is very high in potassium and exceptionally high in rubidium. Since the soil is volcanic it must also be very rich in cesium. These Indians live primarily on desert grown calico corn products. Instead of using baking soda they use the ash of chamisa leaves, a desert grown plant. The analyses of this ash showed it to be very rich in rubidium. The Indians also eat many fruits, especially apricots, per day. They always eat the kernels. The results indicate clearly that the Hopi food meets the requirements for the High pH therapy.
The ready uptake of cesium and rubidium by the cancer cells lead the writer to the High pH therapy. This consists of feeding the patient close to 6 g of CsCl or RbCl per day in conjunction with the administration of ascorbic and retionic acids, Vitamins C and A, which being weak acids, upon absorption by the tumor cells will enhance the negative potential gradient across the membrane, and also zinc and selenium salts which, when absorbed on the membrane surface, will act as broad and moderately strong electron donors. Both types of compounds have been shown in mice to drastically enhance the pickup for cesium and rubidium ions. The toxic dose for CsCl is 135 g. The administration of 6 g per day therefore has no toxic effects. It is sufficient however to give rise to the pH in the cancer cells, bringing them up in a few days to the 8 or above where the life of the cell is short. In addition, the presence of Cs and Rb salts in the body fluids neutralizes the acid toxins leaking out of the tumor mass and renders them nontoxic.
Tests on Mice - The High pH therapy was first tested at American University in Washington, DC using mice. In these tests, 2 mm cubes of mammary tumors were implanted in the abdomens of mice and allowed to grow for 8 days. The mice were then divided into two groups. Both groups were continued on mouse chow, but the test group was given 1.11 g of rubidium carbonate by mouth per day in aqueous solution. After 13 more days the controls were starting to die so all mice were sacrificed and the tumors removed and weighed. The tumors in the test animals weighed only one eleventh of those in the controls. In addition, the test animals were showing none of the adverse effects of having cancer [3]. Results similar to those mentioned above were obtained at Platteville, WI using CsCl. More recently, Platteville has studied intraperitoneal injection of cesium carbonate for mice with abdominal tumor implants with 97% curative effect. Tests using intraperitoneal injections of CsCl were carried out by Messiha et al. [21]. The results were most successful and showed a drastic shrinkage in the tumor masses.
Tests on Man - Many tests on humans have been carried out by H. Nieper in Hannover, Germany and by H. Sartori in Washington, DC as well as by a number of other physicians. On the whole, the results have been very satisfactory. It has been observed that all pains associated with cancer disappear within 12 to 24 hr, except in a very few cases where there was a morphine withdrawal problem that required a few more hours. In these tests 2 g doses of CsCl were administered three times per day after eating. In most cases 5 to 10 g of Vitamin C and 100,000 units of Vitamin A, along with 50 to 100 mg of zinc, were also administered. Both Nieper and Sartori were also administering nitrilosides in the form of laetrile. There are good reasons to believe that the laetrile may be more effective than the vitamins in enhancing the pickup of cesium by the cells. In addition to the loss of pains, the physical results are a rapid shrinkage of the tumor masses. The material comprising the tumors is secreted as uric acid in the urine; the uric acid content of the urine increases many fold. About 50% of the patients were pronounced terminal, and were not able to work. Of these, a majority have gone back to work. Two side effects have been observed in some of the patients. These are first nausea, and the second diarrhea. Both depend upon the general condition of the digestive tract. Nieper feels that nausea can be prevented by administering the cesium in a solution of sorbitol. The diarrhea may, to some extent, be affected by the Vitamin C.
Only one case history will be presented here. A woman with 2 hard tumor masses 8 to 10 cm in diameter, one on her thyroid and one on her chest, was given 3 to 6 months to live. She had been subjected to chemotherapy, but was discontinued because it weakened her. She was taking laetrile on her own. She was given a 50 g bottle of CsCl and was told to take 4 g per day. She reported her case a year later. Being very frightened she took the entire 50 g in one week. At the end of that time the tumor masses were very soft, so she obtained another 50 g of CsCl and took it in another week. By the end of that time she could not find the tumors, and two years later there was no sign of their return. [Note: Dr. Hans Alfred Nieper, of Hannover, Germany, (now passed) was an oncologist consulted by prominent persons including Red Buttons, Yul Brynner and Ronald Reagan. He was president of the German Society of Oncology].
The Hopi Indians of Arizona - The incidence of cancer among the Hopi Indians is 1 in 1000 as compared to 1 in 4 for the USA as a whole. Fortunately their food has been analyzed from the standpoint of nutritional values [17]. In this study it was shown that the Hopi food runs higher in all the essential minerals than conventional foods. It is very high in potassium and exceptionally high in rubidium. Since the soil is volcanic it must also be very rich in cesium. These Indians live primarily on desert grown calico corn products. Instead of using baking soda they use the ash of chamisa leaves, a desert grown plant. The analyses of this ash showed it to be very rich in rubidium. The Indians also eat many fruits, especially apricots, per day. They always eat the kernels. The results indicate clearly that the Hopi food meets the requirements for the High pH therapy.
EVIDENCE LIQUID CESIUM CHLORIDE KILLS CANCER CELLS
1. American Cancer Society: "Studies conducted in several experimental tumor models in the 1980s found that the use of cesium or liquid cesium chloride led to less tumor growth and fewer deaths of certain tumor-bearing mice such as those with sarcoma or breast cancer." Note - No study information provided.
2. In a study conducted by the Prostate Center at Vancouver General Hospital, researchers found liquid cesium chloride reduced tumor growth in some tumors, but not others. "The purpose of this study was to assess the therapeutic and toxicological effects of cesium chloride (CsCl) administration in mice bearing prostate cancer tumors. METHODS: Three CsCl dose titration studies were completed in tumor-bearing and non-tumor-bearing athymic nude mice. All mice were administered either vehicle (controls), 150, 300, 600, 800, 1,000, or 1,200 mg/kg of CsCl once daily by oral gavage for 30 consecutive days. RESULTS: Administration of 800-1,200 mg/kg CsCl reduced PC-3 tumor growth but had no effect on LNCaP tumors. Administration of 800-1,200 mg/kg CsCl also resulted in increased water consumption, bladder crystal development, and higher prevalence of cardiac fibrin clots. CsCl may have a therapeutic effect against prostate cancer, but one cannot overlook the acute toxicities also described. [http://www.ncbi.nlm.nih.gov/pubmed/17294190]
3. The present study was conducted in Biology Laboratory of Faculty Sciences and Arts, University of Dumlupinar, Ktahya between january 2001 and july 2002: "Cesium chloride; cesium chloride and magnesium chloride mixture were most affected as the shrinkage on KAC cells, at 95 and 97% rations (p<0.001). CsCl and MgCl2 were most effected on SC cells than other agents (95 and 96%, p<0.001). Inhibition rates of tortoise shell, sponge, frog larva, eat fly larva, medusa and juniper berries extracts on SK cells were respectively 83, 88, 65, 78, 89 and 88% in G0 phase (p<0.001). These data suggest that some biological extracts and chemicals tested may be useful chemotherapeutic agents to inhibit the growth of cancer cells and this study would be a light for new anticancerogenic experiments and preventing various human cancers." [http://scialert.net/abstract/reply.php?doi=jms.2004.1.10&cid=572]
2. In a study conducted by the Prostate Center at Vancouver General Hospital, researchers found liquid cesium chloride reduced tumor growth in some tumors, but not others. "The purpose of this study was to assess the therapeutic and toxicological effects of cesium chloride (CsCl) administration in mice bearing prostate cancer tumors. METHODS: Three CsCl dose titration studies were completed in tumor-bearing and non-tumor-bearing athymic nude mice. All mice were administered either vehicle (controls), 150, 300, 600, 800, 1,000, or 1,200 mg/kg of CsCl once daily by oral gavage for 30 consecutive days. RESULTS: Administration of 800-1,200 mg/kg CsCl reduced PC-3 tumor growth but had no effect on LNCaP tumors. Administration of 800-1,200 mg/kg CsCl also resulted in increased water consumption, bladder crystal development, and higher prevalence of cardiac fibrin clots. CsCl may have a therapeutic effect against prostate cancer, but one cannot overlook the acute toxicities also described. [http://www.ncbi.nlm.nih.gov/pubmed/17294190]
3. The present study was conducted in Biology Laboratory of Faculty Sciences and Arts, University of Dumlupinar, Ktahya between january 2001 and july 2002: "Cesium chloride; cesium chloride and magnesium chloride mixture were most affected as the shrinkage on KAC cells, at 95 and 97% rations (p<0.001). CsCl and MgCl2 were most effected on SC cells than other agents (95 and 96%, p<0.001). Inhibition rates of tortoise shell, sponge, frog larva, eat fly larva, medusa and juniper berries extracts on SK cells were respectively 83, 88, 65, 78, 89 and 88% in G0 phase (p<0.001). These data suggest that some biological extracts and chemicals tested may be useful chemotherapeutic agents to inhibit the growth of cancer cells and this study would be a light for new anticancerogenic experiments and preventing various human cancers." [http://scialert.net/abstract/reply.php?doi=jms.2004.1.10&cid=572]
EVIDENCE OF DMSO EFFECTIVENESS IN CANCER TREATMENT
1. [www.cancertutor.com/Dmso/DmsoArticle.html]
2. American Cancer Society on DMSO: "Recent research in rats has shown that DMSO may deserve further study as a drug carrier used to enhance the effectiveness of some chemotherapy agents for the treatment of bladder cancer."
2. American Cancer Society on DMSO: "Recent research in rats has shown that DMSO may deserve further study as a drug carrier used to enhance the effectiveness of some chemotherapy agents for the treatment of bladder cancer."
